Invention Grant
![Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors](/docs/US/2012-01-17/US08097621B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors
- Patent Title (中): 吡唑并[4,3-d]嘧啶，为磷酸二酯酶抑制剂
-
Application No.: US12481939Application Date: 2009-06-10
-
Publication No.: US08097621B2Publication Date: 2012-01-17
- Inventor: Andrew Simon Bell , David Graham Brown , Kevin Dack , David Nathan Abraham Fox , Ian Roger Marsh , Andrew Ian Morrell , Michael John Palmer , Carol Ann Winslow
- Applicant: Andrew Simon Bell , David Graham Brown , Kevin Dack , David Nathan Abraham Fox , Ian Roger Marsh , Andrew Ian Morrell , Michael John Palmer , Carol Ann Winslow
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Robert T. Ronau; Gregg Benson
- Priority: GB0327319.0 20031124
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P9/12 ; A61P25/28 ; A61P11/06 ; A61P15/10
![Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors](/abs-image/US/2012/01/17/US08097621B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to compounds of formula (I)
Public/Granted literature
- US20090247539A1 Novel Pharmaceuticals Public/Granted day:2009-10-01
Information query
